Search results for "critical limb ischemia"

showing 10 items of 23 documents

Women and peripheral arterial disease: same disease, different issues

2008

Objectives Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are likely to present gender-specific differences with respect to their development, course, symptom complexes and prognosis. The present study aimed to examine sex differences in peripheral arterial disease (PAD) and its clinical correlates. Methods PAD severity, quality of life (assessed by ST-22), cardiovascular risk factors, inflammatory profile and comorbidity were assessed in 163 men and 68 women who were consecutively diagnosed with PAD at three Italian University vascular centres. Results Compared to men, women showed a higher prevalence of critical limb ischemia (P = 0.018), but had a less…

Malemedicine.medical_specialtyArterial diseaseDiseaseComorbiditySeverity of Illness IndexStatistics NonparametricQuality of lifeperipheral arterial diseaseRisk FactorsInternal medicineSeverity of illnessgenderPrevalenceMedicineHumansSex DistributionInflammationPeripheral Vascular DiseasesLegChi-Square Distributionbusiness.industryMultifactorial diseaseCritical limb ischemiaintermittent claudicationGeneral Medicinemedicine.diseaseAtherosclerosisComorbidityPeripheralLogistic ModelsItalyQuality of LifeFemaleCardiology and Cardiovascular MedicinebusinessChi-squared distribution
researchProduct

Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery.

2013

Background The purpose of this study was to analyze the long-term results of infrainguinal bypass surgery using the deep femoral artery (DFA) as the inflow source. Methods Between 1998 and 2011, 88 bypasses of the lower limb were placed in 86 patients (mean age 71 years) using the deep femoral artery as inflow. Patients' records were retrieved from a computerized database and analyzed retrospectively. Results Critical limb ischemia (rest pain/tissue loss) was the indication in the majority (87.5%) of cases. The distal anastomosis of the bypass grafts was located at the popliteal level in 32 cases and the tibial (pedal) level in 52 cases, respectively, with the autologous vein as conduit in …

Malemedicine.medical_specialtyTime FactorsInfrainguinal bypassCritical IllnessInflowFemoral arteryKaplan-Meier EstimateIschemiamedicine.arterymedicineDeep Femoral ArteryHumansVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesGroinbusiness.industryGeneral MedicineCritical limb ischemiaPerioperativeMiddle Agedmedicine.diseaseLimb SalvageSurgeryFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremitySurgeryVascular GraftingRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationAnnals of vascular surgery
researchProduct

Trans-popliteal hybrid retrograde technique for revascularization of chronic total occlusions of the superficial femoral artery.

2020

Objectives We present the technical description and preliminary results of a hybrid approach for the treatment of chronic total occlusions of superficial femoral artery in the setting of critical limb-threatening ischemia (CLTI). Methods A retrospective analysis of selected case series was performed. A trans-popliteal hybrid technique was carried out in seven limbs (six patients). Open exposure of above-the-knee popliteal artery was performed over its maximum calcification zone. After retrograde recanalization and graft-stenting of the entire superficial femoral artery, endarterectomy of the popliteal artery was performed for debulking and widening of the distal landing zone of the endopros…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCritical IllnessConstriction PathologicEndarterectomy030204 cardiovascular system & hematologyRevascularization030218 nuclear medicine & medical imaging03 medical and health sciencesBlood Vessel Prosthesis ImplantationPeripheral Arterial Disease0302 clinical medicineIschemiamedicineHumansRadiology Nuclear Medicine and imagingPopliteal ArteryVascular PatencyAgedRetrospective Studiesbusiness.industrySuperficial femoral arteryEndovascular ProceduresGeneral MedicineCritical limb ischemiaMiddle Agedmedicine.diseaseHybrid approachBlood Vessel ProsthesisFemoral ArteryTreatment OutcomeChronic DiseaseRetrograde approachSurgeryFemaleStentsRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationVascular
researchProduct

Impact of endovascular treatment on clinical status and health-related quality of life.

2008

Background and Aims: Investigating the impact of percutaneous transluminal angioplasty (PTA) on clinical status and health related quality of life in patients with claudication and critical limb ischaemia (CLI). Material and Methods: 61 patients and 64 limbs underwent a primary PTA (30 claudication and 34 CLI cases). Clinical status was graded according to Ahn and Rutherford and ankle/brachial index (ABI). Quality of life was assessed using the Nottingham Health Profile (NHP) preoperatively, one month and one year after the procedure. Triplex scan evaluation of the treated arterial segment was carried out postoperatively and one year after the procedure. Results: Claudication: 24/27 patient…

Malemedicine.medical_specialtymedicine.medical_treatmentRevascularizationStatistics NonparametricRestenosisIschemiamedicineHumansProspective StudiesAgedLegbusiness.industryCritical limb ischemiaIntermittent Claudicationmedicine.diseaseIntermittent claudicationSurgeryNottingham Health ProfileTreatment OutcomeBypass surgeryAmputationQuality of LifeSurgeryFemalemedicine.symptombusinessClaudicationAngioplasty BalloonScandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
researchProduct

Rheopheresis in Patients with Critical Limb Ischemia--Results of an Open Label Prospective Pilot Trial

2005

Rheopheresis is a specifically designed application of double filtration plasmapheresis, for extracorporeal treatment of microcirculatory disorders. Safety and efficacy of Rheopheresis for wound healing and skin oxygenation were investigated in patients with critical limb ischemia. Twelve patients of Fontaine stage III-IV were treated with a series of 10 Rheopheresis sessions over 17 weeks. Transcutaneous oxygen pressure (tcpO(2)) and ankle-brachial index (ABI) were repeatedly determined to monitor the effects of the Rheopheresis treatment series on microcirculation and skin blood flow. Laboratory parameters of blood rheology were measured in addition to safety parameters and course of the …

Malemedicine.medical_specialtymedicine.medical_treatmentRheopheresisPilot ProjectsExtracorporealMicrocirculationIschemiamedicineHumansalpha-MacroglobulinsProspective StudiesProspective cohort studyAgedSkinWound Healingbusiness.industryFibrinogenProteinsCholesterol LDLPlasmapheresisHematologyCritical limb ischemiaOxygenationMiddle AgedSurgeryClinical trialTreatment OutcomeImmunoglobulin MLower ExtremityAmputationRegional Blood FlowNephrologyFemalemedicine.symptombusinessBlood Gas Monitoring TranscutaneousTherapeutic Apheresis and Dialysis
researchProduct

Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia

2016

Femoro-popliteal PTA for the treatment of critical limb ischemia is frequently associated with unsatisfactory procedural success rates while directional atherectomy (DCA) has improved success rate since claudicant patients undergoing percutaneous treatment of femoro-popliteal obstructive disease. The aim of this prospective study is to evaluate the safety, efficacy and procedural success of DCA, at one year, in the percutaneous treatment of femoro-popliteal obstructive disease in patients with critical limb ischemia.Methods. From March 2012 to March 2013 18 consecutive patients with critical limb ischemia were treated with DCA (Turbohawk/ Covidien-ev3 Endovascular Inc., North Plymouth, Minn…

critical limb ischemiaendovascular treatmentTurbohawk device; atherectomy; critical limb ischemia; endovascular treatmentArticlesatherectomyTurbohawk deviceSettore MED/22 - Chirurgia Vascolare
researchProduct

Critical limb ischaemia: definition and natural hystory

2004

The term critical limb ischemia refers to a condition characterized by chronic ischemic at-rest pain, ulcers, or gangrene in one or both legs attributable to objectively proven arterial occlusive disease. Critical limb ischemia implies chronicity and is to be distinguished from acute limb ischemia. Its incidence is approximately 500 to 1000 per million year, with the highest rates among older subjects, smokers and diabetics. The rate of primary amputation ranges from 10% to 40%, and was performed only when no graftable distal vessels were present, or in neurologically impaired or hopelessly nonambulatory patients. Contrarily, in some highly specialized and aggressive centres about 90% of pa…

critical limb ischemiamedicine.medical_specialtyArteriosclerosismedicine.medical_treatmentRevascularizationAmputation SurgicalGangrenearterial occlusive diseaseIschemiaRisk Factorscardiovascular mortalityInternal medicinePeripheral arterial diseaseMedicineHumansMyocardial infarctionStrokePharmacologyGangrenePeripheral Vascular DiseasesLegbusiness.industryFootcardiovascular morbiditysurgical revascularizationHematologyCritical limb ischemiamedicine.diseaseIntermittent claudicationFontaine’s classificationSurgerybody regionsNatural historyAmputationrisk factors amputationCardiologyMolecular Medicinemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Subintimal stenting for superficial femoral artery long occlusion in patients with critical limb ischemia

2010

Introduction: Subintimal recanalization of chronic totally occluded superficial femoral arteries (SFA) has gained increasing attention as an effective approach for limb salvage in patients with critical limb ischemia (CLI). Use of stents in treating SFA lesions has increased with the intention to improve arterial patency. Our aim was to evaluate the feasibility and mid-term outcomes of subintimal stenting in long occlusions of the SFA in patients presenting CLI. Methods: A retrospective review of consecutive patients admitted to our unit with chronic occlusion of the SFA and CLI between september 2008 and september 2010 was performed. Within this group, the subintimal angioplasty with prima…

endovascular treatmentCritical limb ischemiastentSettore MED/22 - Chirurgia Vascolare
researchProduct

Simultaneous Hybrid Treatment of Multilevel Peripheral Arterial Disease in Patients with Chronic Limb-Threatening Ischemia

2021

Background: Hybrid treatments (HT) aim to reduce conventional open surgery invasiveness and address multilevel peripheral arterial disease (PAD). Herein, the simultaneous HT treatment in patients with chronic limb-threatening ischemia (CLTI) is reported. Methods: Retrospective analysis, for the period from May 2012 to April 2018, of patients presenting multilevel PAD with CLTI addressed with simultaneous HT. The outcomes of these interventions were measured the following metrics: early technical successes (within 30 days following treatment) and late technical successes (30 days or more following treatment) and included mortality, morbidity symptoms recurrence, and amputation. Survival and …

endovascular treatmentcritical limb ischemiamedicine.medical_specialtyArterial diseasemedicine.medical_treatmentIschemiaFemoral arterysimultaneous030204 cardiovascular system & hematologySettore MED/22 - Chirurgia VascolareArticle03 medical and health sciences0302 clinical medicineperipheral arterial diseasemedicine.arterymedicineIn patient030212 general & internal medicinebusiness.industryRGeneral MedicineCritical limb ischemiaPerioperativemedicine.diseaseSurgeryPeripheralAmputationMedicinehybrid treatmentmedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

2020

[This corrects the article DOI: 10.3389/fimmu.2019.01151.].

lcsh:Immunologic diseases. Allergycritical limb ischemiamedicine.medical_specialtyclinical trialsdiabetesbusiness.industrycost-effectivecell-based therapyImmunologyType 2 Diabetes MellitusCorrectionCritical limb ischemiamedicine.diseasecellular medicamentsCell therapyClinical trialDiabetes mellitusInternal medicinemedicineImmunology and Allergymedicine.symptombusinesslcsh:RC581-607
researchProduct